Hot Life Science Investor Mandate 3: VC Seeks Medical Devices and Healthcare Services for Chinese Market

9 Jul

A China-based healthcare-specific RMB fund has raised three funds to date and is now investing from its recently closed third fund. The firm is actively seeking to invest in early-growth and revenue-stage China-based companies, and also considers offshore companies that have significant operations in China or products that are strongly applicable to the Chinese market.

The firm is currently seeking companies in the healthcare service sector, which includes healthcare record management systems, healthcare IT, and mobile health. The firm is also interested in innovative medical devices that have large market potential. The firm is agnostic to therapeutic indications, but is not interested in large hospital equipment. The firm looks for companies that have “disruptive” technologies and/or products or business models that are game-changing. The firm prefers early-growth and revenue-stage companies, while it also invest in select early ventures that seek to establish critical infrastructures and platforms in the evolving Chinese healthcare industry.

The firm invests in entrepreneurs who have unique insights, exceptional domain knowledge and deep operational experience. In particular, the firm looks for management teams with successful track records in China.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: